Search images on Google      Product Monograph

Active Ingredients:

• lanadelumab, 300 MG/2 ML

DIN: 02505614

Dosage Form(s): SOLUTION

Route(s) of Administration: SUBCUTANEOUS

Description: 2 ML PREFILLED SYRINGE

Schedule: Prescription

Company: TAKEDA CANADA INC  –  official site

ATC:

• B06 - OTHER HEMATOLOGICAL AGENTS (ATC, WHO, Wiki)
• B06A - OTHER HEMATOLOGICAL AGENTS (ATC, WHO)
• B06AC - (ATC, WHO)
• B06AC05 - LANADELUMAB (WHO)

 

External Links for Takhzyro:

Search on Google

• Takhzyro side effects
• Takhzyro dosage
• lanadelumab side effects
• lanadelumab dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find takhzyro photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.